VANCOUVER, British Columbia, July 13, 2021 (GLOBE NEWSWIRE) — Optimi Health Corp. (CSE: OPTI) (OTC: OPTHF) (FRA: 8BN) (“Optimi” or the “Company”), a vertically integrated developer of mushroom products is pleased to announce its inclusion in the first psychedelics Exchange Traded Fund (“ETF”) (NEO: PSYK). The ETF began trading on the Neo Exchange as of January 26, 2021. The ETF invests in…


Previous articleActive vs. Passive Coping Distinguishes Antidepressants and Psychedelics
Next articlePTSF72 – Breaking Down SB-519, with MAPS’ Ismail L. Ali